You are here

GSK opens S$130m facilities in Jurong

New plant and expanded building will step up pharmaceutical firm's output of active ingredients in its HIV medication

Mr Chan (centre, right) notes that data-driven flexibility is the future of the pharmaceutical industry.


PHARMACEUTICAL giant GlaxoSmithKline (GSK) unveiled a new, fully automated continuous manufacturing facility and an expanded production building at its Jurong site on Friday, worth a total of S$130 million.

The site upgrades will accelerate GSK's global supply chain and,...